Market Tracker

09/23 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.84
Delayed Data
As of Sep 23
 -0.0266 / -0.34%
Today’s Change
5.46
Today|||52-Week Range
10.74
-8.26%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.87
Today’s open7.87
Day’s range7.83 - 7.96
Volume35,741
Average volume (3 months)93,128
Market cap$103.0M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.01-0.61%
CPRXCatalyst Pharmaceuti...+0.14+12.61%
GEMPGemphire Therapeutic...-0.70-6.03%
PPHMPeregrine Pharmaceut...-0.01-2.31%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts